StockData
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. (PPCB) income statement

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.88−0.01 (-0.53%)

Close on Nov 17, 2026Market cap $1.85MP/E –Yield –

Propanc Biopharma, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-161.9%

Financial strength

Current ratio
2.47
Debt to equity
–
Debt to assets
–
Cash to current liabilities
8.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.26
Dividend yield
–

See a number that looks wrong?